Prognostic impact of dose, duration, and timing of corticosteroid therapy in patients with large B-cell lymphoma treated with standard of care axicabtagene ciloleucel (Axi-cel).

Authors

Ranjit R. Nair MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

5-2020

Volume

38

Published In/Presented At

Paolo Strati et al.,

Prognostic impact of dose, duration, and timing of corticosteroid therapy in patients with large B-cell lymphoma treated with standard of care axicabtagene ciloleucel (Axi-cel).. JCO 38, 8011-8011(2020).

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine, Hematology-Medical Oncology Division, Lehigh Valley Topper Cancer Institute

Document Type

Article